Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer.

Saved in:
Bibliographic Details
Title: Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer.
Authors: Ali S; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan., Arshad M; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan., Summer M; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan., Zulfiqar M; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan., Noor S; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan., Nazakat L; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan., Javed MA; Medical Toxicology and Biochemistry Laboratory, Department of Zoology, Government College University, Lahore, Pakistan.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2025 Oct; Vol. 31 (7), pp. 1115-1144. Date of Electronic Publication: 2025 Mar 28.
Publication Type: Journal Article; Review
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-092X
DOI:10.1177/10781552251324896